Clinical Cancer Research: 2 (5)

How do lymphocytes kill tumor cells?

T A Graubert and T J Ley

Clin Cancer Res May 1 1996 2 (5) 785-789;
Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2-checkpoint inhibitor.

R T Bunch and A Eastman

Clin Cancer Res May 1 1996 2 (5) 791-797;
Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents.

W Zhang, M A Piatyszek, T Kobayashi, E Estey, M Andreeff, A B Deisseroth, W E Wright and J W Shay

Clin Cancer Res May 1 1996 2 (5) 799-803;
Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.

R G Lapidus, A T Ferguson, Y L Ottaviano, F F Parl, H S Smith, S A Weitzman, S B Baylin, J P Issa and N E Davidson

Clin Cancer Res May 1 1996 2 (5) 805-810;
Dynamic expression changes in vivo of adhesion and costimulatory molecules determine load and pattern of lymphoma liver metastasis.

M Rocha, A Krüger, V Umansky, P von Hoegen, D Naor and V Schirrmacher

Clin Cancer Res May 1 1996 2 (5) 811-820;
Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients.

Y Yamamoto, M Toi, S Kondo, T Matsumoto, H Suzuki, M Kitamura, K Tsuruta, T Taniguchi, A Okamoto, T Mori, M Yoshida, T Ikeda and T Tominaga

Clin Cancer Res May 1 1996 2 (5) 821-826;
Tumor necrosis factor alpha enhances secretion of transforming growth factor beta2 in MCF-7 breast cancer cells.

D N Danforth Jr and M K Sgagias

Clin Cancer Res May 1 1996 2 (5) 827-835;
Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum.

J J Kavanagh, A P Kudelka, C G de Leon, D Tresukosol, M Hord, M B Finnegan, E E Kim, D Varma, A Forman, P Cohen, C L Edwards, R S Freedman and C F Verschraegen

Clin Cancer Res May 1 1996 2 (5) 837-842;
Enhancement of radiosensitivity in human malignant glioma cells by hypericin in vitro.

W Zhang, L Anker, R E Law, D R Hinton, R Gopalakrishna, Q Pu, U Gundimeda, M H Weiss and W T Couldwell

Clin Cancer Res May 1 1996 2 (5) 843-846;
Paclitaxel induces programmed cell death in MDA-MB-468 human breast cancer cells.

D E McCloskey, S H Kaufmann, L J Prestigiacomo and N E Davidson

Clin Cancer Res May 1 1996 2 (5) 847-854;
Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines.

N Oridate, D Lotan, X C Xu, W K Hong and R Lotan

Clin Cancer Res May 1 1996 2 (5) 855-863;
Vulnerability of multidrug-resistant tumor cells to the aromatic fatty acids phenylacetate and phenylbutyrate.

S Shack, A Miller, L Liu, P Prasanna, A Thibault and D Samid

Clin Cancer Res May 1 1996 2 (5) 865-872;
Retroviral transfer and expression of the human multiple drug resistance (MDR) gene in peripheral blood progenitor cells.

M Ward, P Pioli, J Ayello, R Reiss, G Urzi, C Richardson, C Hesdorffer and A Bank

Clin Cancer Res May 1 1996 2 (5) 873-876;
Human lung cancer cells endogenously expressing mutant p53 process and present the mutant epitope and are lysed by mutant-specific cytotoxic T lymphocytes.

I F Ciernik, J A Berzofsky and D P Carbone

Clin Cancer Res May 1 1996 2 (5) 877-882;
Chromosome-specific aneusomy in carcinoma of the breast.

D L Persons, R A Robinson, P H Hsu, S A Seelig, T J Borell, L C Hartmann and R B Jenkins

Clin Cancer Res May 1 1996 2 (5) 883-888;
Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma.

J L Mohler, Y Chen, K Hamil, S H Hall, J A Cidlowski, E M Wilson, F S French and M Sar

Clin Cancer Res May 1 1996 2 (5) 889-895;
Placental site trophoblastic tumor: molecular analysis and clinical experience.

M Bower, F J Paradinas, R A Fisher, S K Nicholson, G J Rustin, R H Begent, K D Bagshawe and E S Newlands

Clin Cancer Res May 1 1996 2 (5) 897-902;
Allelic loss and replication errors at microsatellite loci on chromosome 11p in head and neck squamous carcinoma: association with aggressive biological features.

A K El-Naggar, K Hurr, V Huff, M A Luna, H Goepfert and J G Batsakis

Clin Cancer Res May 1 1996 2 (5) 903-907;
Further evidence for prognostic significance of epidermal growth factor receptor gene amplification in patients with esophageal squamous cell carcinoma.

Y Kitagawa, M Ueda, N Ando, S Ozawa, N Shimizu and M Kitajima

Clin Cancer Res May 1 1996 2 (5) 909-914;
bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time.

Y Ohsaki, E Toyoshima, S Fujiuchi, H Matsui, S Hirata, N Miyokawa, Y Kubo and K Kikuchi

Clin Cancer Res May 1 1996 2 (5) 915-920;

Main menu

User menu

Search

Table of Contents

Articles

Info for

About Clinical Cancer Research